Participants of the Project

Several leading Russian and international innovative companies are participating in project. The partners’ participation in the SynBio is a project aimed at creating innovative medicines, including what are known as Biobetters. joint venture is structured as follows (following the conclusion of the preliminary phase of the project and the entry of Rusnano): 

One of the leading R&D partners of the project is the British-based Lipoxen, which develops medicines in partnership with the world’s leading pharmaceutical producers. Also participating in the project is the German company SymbioTec (which will merge into Lipoxen in the near future).